Concepedia

Mordechai Rabinovitz

MR

Statistics

Publications

65

Citations

5.7K

H-Index

37

Active since

1958

Affiliations

University of Pittsburgh(Current)

University of Pittsburgh Medical Center

University of Toronto

UPMC Health System

The University of Texas at San Antonio Health Science Center

Mordechai Rabinovitz is an author at University of Pittsburgh specializing in medicine, hepatology, and liver disease.

Publications per year

1958–2020

65

Publications

65

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Eric Lawitz, Mark Sulkowski, Reem Ghalib et al. · The Lancet · 2014 · 818 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

David R. Nelson, James N. Cooper, Jacob Lalezari et al. · Hepatology · 2015 · 689 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Surgically-Induced Weight Loss Significantly Improves Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome

Samer G. Mattar, Laura Velcu, Mordechai Rabinovitz et al. · Annals of Surgery · 2005 · 339 citations · Full text

Medicine, Nutritional Sciences, Surgery +12

Liver disease selectively modulates cytochrome P450–mediated metabolism

Reginald F. Frye, N ZGHEIB, Gary R. Matzke et al. · Clinical Pharmacology & Therapeutics · 2006 · 246 citations

Medicine, Pharmacology, Biochemical Pharmacology +16

Orthotopic Liver Transplantation for Alcoholic Liver Disease

Shashi Kumar, Rudolf Stauber, Judith S. Gavaler et al. · Hepatology · 1990 · 236 citations · Full text

Medicine, Surgery, Hepatology +13

1–5 of 65